Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-032073

Options or other derivatives

  • General Counsel/Secretary acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Leavitt Chase C. General Counsel/Secretary 2019-05-20 Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/doc4.xml…